Product Information
DAPSONE 5% GEL is a generic product labeled by Pacific Pharma, Inc., priced at $0.6700 per GM under NDC 60758067090. Its NADAC has been published 431 times since May 23, 2018.
FDA first approved this application on Jul 7, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/g
Manufacturer
Pacific Pharma, Inc.NDC
60758067090
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
DAPSONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021794FDA Approved
7/7/2005
TE Code
AB
On Market Since
10/18/2017
Pharmacological Classes
Price Statistics
The NADAC for DAPSONE 5% GEL has been published 431 times since May 23, 2018, and over the history we have for it it has declined 86.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6700 per GM |
|---|---|
| All-time high | $5.1445 (Sep 11, 2019) |
| All-time low | $0.6597 (Jul 22, 2026) |
| 52-week high | $1.2376 |
| 52-week low | $0.6597 |
| Median price | $2.8326 |
| Average price | $2.8351 |
| Largest weekly change | -34.7% (Sep 18, 2019) |
| Weeks tracked | 431 |
| Tracking since | May 23, 2018 |
1W
N/A
1M
N/A
3M
-21.8%
6M
-23.6%
1Y
-45.9%
3Y
-76.3%
5Y
-76.2%
All
-86.7%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pacific Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dapsone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sulfone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DAPSONE 5% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DAPSONE 5% GEL, manufactured by Pacific Pharma, Inc., is $0.6700 per GM (NDC 60758067090), effective Aug 19, 2026.
How has the price of DAPSONE 5% GEL changed over time?
Over the history we have for it, the NADAC for DAPSONE 5% GEL has declined 86.7%. It has been tracked across 431 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for DAPSONE 5% GEL?
Since May 23, 2018, the NADAC for DAPSONE 5% GEL has ranged from a low of $0.6597 (Jul 22, 2026) to a high of $5.1445 (Sep 11, 2019), with a median of $2.8326 per GM.
Are there cheaper alternatives to DAPSONE 5% GEL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DAPSONE 5% GEL, is $0.6638 per GM — about 1% below DAPSONE 5% GEL.
Who manufactures DAPSONE 5% GEL?
DAPSONE 5% GEL (NDC 60758067090) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.